Differential microglial regulation in the human spinal cord under normal and pathological conditions

Neuropathology and Applied Neurobiology

Volumn 32, Issue 6, 2006, Pages 650-661

  Stoll, M ^a   Capper, D ^a   Dietz, K ^a   Warth, A ^b   Schleich, A ^a   Schlaszus, H ^a   Meyermann, R ^a   Mittelbronn, M ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Human; Microglia; Regulation; Spinal cord

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; CD4 ANTIGEN; INTERLEUKIN 16; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADULT; AGED; ARTICLE; CELL POPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; GRAY MATTER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD LESION; WHITE MATTER;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MIDDLE AGED; SPINAL CORD; SPINAL CORD DISEASES;

EID: 33750589667     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2006.00774.x     Document Type: Article

References (53)

1. Rezaie P, Male D. Mesoglia & microglia - a historical review of the concept of mononuclear phagocytes within the central nervous system. J Hist Neurosci 2002; 11: 325-74
2. Graeber MB, Scheithauer BW, Kreutzberg GW. Microglia in brain tumors. Glia 2002; 40: 252-9
3. Streit WJ. Microglial response to brain injury: a brief synopsis. Toxicol Pathol 2000; 28: 28-30
4. Streit WJ. Microglia and Alzheimer's disease pathogenesis. J Neurosci Res 2004; 77: 1-8
5. Hess DC, Abe T, Hill WD, Studdard AM, Carothers J, Masuya M, Fleming PA, Drake CJ, Ogawa M. Hematopoietic origin of microglial and perivascular cells in brain. Exp Neurol 2004; 186: 134-44
6. Ulvestad E, Williams K, Bjerkvig R, Tiekotter K, Antel J, Matre R. Human microglial cells have phenotypic and functional characteristics in common with both macrophages and dendritic antigen-presenting cells. J Leukoc Biol 1994; 56: 732-40
7. Frei K, Lins H, Schwerdel C, Fontana A. Antigen presentation in the central nervous system. The inhibitory effect of IL-10 on MHC class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed. J Immunol 1994; 152: 2720-8
8. Lee YB, Nagai A, Kim SU. Cytokines, chemokines, and cytokine receptors in human microglia. J Neurosci Res 2002; 69: 94-103
9. Schnell L, Fearn S, Klassen H, Schwab ME, Perry VH. Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord. Eur J Neurosci 1999; 11: 3648-58
10. Mittelbronn M, Dietz K, Schluesener HJ, Meyermann R. Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitude. Acta Neuropathol 2001; 101: 249-55
11. Ling EA. Study in the changes of the proportions and numbers of the various glial cell types in the spinal cord of neonatal and young adult rats. Acta Anat 1976; 96: 188-95
12. Vass K, Lassmann H. Intrathecal application of interferon gamma. Progressive appearance of MHC antigens within the rat nervous system. Am J Pathol 1990; 137: 789-800
13. Wierzba-Bobrowicz T, Kosno-Kruszewska E, Gwiazda E, Lechowicz W, Schmidt-Sidor B. Major histocompatibility complex class II (MHC II) expression in the normal and pathological human foetal spinal cord. Folia Neuropathol 2001; 39: 49-56
14. Schmitt AB, Buss A, Breuer S, Brook GA, Pech K, Martin D, Schoenen J, Noth J, Love S, Schroder JM, Kreutzberg GW, Nacimiento W. Major histocompatibility complex class II expression by activated microglia caudal to lesions of descending tracts in the human spinal cord is not associated with a T cell response. Acta Neuropathol 2000; 100: 528-36
15. Horikoshi Y, Sasaki A, Taguchi N, Maeda M, Tsukagoshi H, Sato K, Yamaguchi H. Human GLUT5 immunolabeling is useful for evaluating microglial status in neuropathological study using paraffin sections. Acta Neuropathol 2003; 105: 157-62
16. Sasaki A, Yamaguchi H, Horikoshi Y, Tanaka G, Nakazato Y. Expression of glucose transporter 5 by microglia in human gliomas. Neuropathol Appl Neurobiol 2004; 30: 447-55
17. Baron P, Bussini S, Cardin V, Corbo M, Conti G, Galimberti D, Scarpini E, Bresolin N, Wharton SB, Shaw PJ, Silani V. Production of monocyte chemoattractant protein-1 in amyotrophic lateral sclerosis. Muscle Nerve 2005; 32: 541-4
18. Rauschka H, Jellinger K, Lassmann H, Braier F, Schmidbauer M. Guillain-Barre syndrome with marked pleocytosis or a significant proportion of polymorphonuclear granulocytes in the cerebrospinal fluid: neuropathological investigation of five cases and review of differential diagnoses. Eur J Neurol 2003; 10: 479-86
19. Nau R, Bruck W. Neuronal injury in bacterial meningitis: mechanisms and implications for therapy. Trends Neurosci 2002; 25: 38-45
20. Shibata M, Ohtani R, Ihara M, Tomimoto H. White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke 2004; 35: 2598-603
21. Turrin NP, Rivest S. Innate immune reaction in response to seizures. implications for the neuropathology associated with epilepsy. Neurobiol Dis 2004; 16: 321-34
22. Jack C, Ruffini F, Bar-Or A, Antel JP. Microglia and multiple sclerosis. J Neurosci Res 2005; 81: 363-73
23. Jellinger K, Radaskiewicz TH, Slowik F. Primary malignant lymphomas of the central nervous system in man. Acta Neuropathol 1975; 6: 95-102
24. Zhou Y, Wang Y, Kovacs M, Jin J, Zhang J. Microglial activation induced by neurodegeneration - A proteomic analysis. Mol Cell Proteomics 2005; 4: 1471-9
25. Utans U, Arceci RJ, Yamashita Y, Russell ME. Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection. J Clin Invest 1995; 95: 2954-62
26. Deininger MH, Meyermann R, Schluesener HJ. The allograft inflammatory factor-1 family of proteins. FEBS Lett 2002; 514: 115-21
27. Postler E, Rimner A, Beschorner R, Schluesener HJ, Meyermann R. Allograft-inflammatory-factor-1 is upregulated in microglial cells in human cerebral infarctions. J Neuroimmunol 2000; 108: 244-50
28. Schwab JM, Frei E, Klusman I, Schnell L, Schwab ME, Schluesener HJ. AIF-1 expression defines a proliferating and alert microglial/macrophage phenotype following spinal cord injury in rats. J Neuroimmunol 2001; 119: 214-22
29. Schluesener HJ, Seid K, Kretzschmar J, Meyermann R. Allograft- inflammatory factor-1 in rat experimental autoimmune encephalomyelitis, neuritis, and uveitis: expression by activated macrophages and microglial cells. Glia 1998; 24: 244-51
30. Perry VH, Gordon S. Modulation of CD4 antigen on macrophages and microglia in rat brain. J Exp Med 1987; 166: 1138-43
31. Center DM, Kornfeld H, Ryan TC, Cruikshank WW. Interleukin 16: implications for CD4 functions and HIV-1 progression. Immunol Today 2000; 21: 273-80
32. Holness CL, Simmons DL. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 1993; 81: 1607-13
33. Falini B, Flenghi L, Pileri S, Gambacorta M, Bigerna B, Durkop H, Eitelbach F, Thiele J, Pacini R, Cavaliere A. PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am J Pathol 1993; 142: 1359-72
34. Center DM, Kornfeld H, Cruikshank WW. Interleukin-16. Int J Biochem Cell Biol 1997; 29: 1231-4
35. Cruikshank WW, Berman JS, Theodore AC, Bernardo J, Center DM. Lymphokine activation of T4+ T lymphocytes and monocytes. J Immunol 1987; 138: 3817-23
36. Mathy NL, Scheuer W, Lanzendorfer M, Honold K, Ambrosius D, Norley S, Kurth R. Interleukin-16 stimulates the expression and production of proinflammatory cytokines by human monocytes. Immunology 2000; 100: 63-9
37. Mathy NL, Bannert N, Norley SG, Kurth R. Cutting edge: CD4 is not required for the functional activity of IL-16. J Immunol 2000; 164: 4429-32
38. Guo LH, Mittelbronn M, Brabeck C, Mueller CA, Schluesener HJ. Expression of interleukin-16 by microglial cells in inflammatory, autoimmune, and degenerative lesions of the rat brain. J Neuroimmunol 2004; 146: 39-45
39. Gehrmann J, Banati RB, Kreutzberg GW. Microglia in the immune surveillance of the brain: human microglia constitutively express HLA-DR molecules. J Neuroimmunol 1993; 48: 189-98
40. Abe M, Umehara F, Kubota R, Moritoyo T, Izumo S, Osame M. Activation of macrophages/microglia with the calcium-binding proteins MRP14 and MRP8 is related to the lesional activities in the spinal cord of HTLV-I associated myelopathy. J Neurol 1999; 246: 358-64
41. Beschorner R, Engel S, Mittelbronn M, Adjodah D, Dietz K, Schluesener HJ, Meyermann R. Differential regulation of the monocytic calcium-binding peptides macrophageinhibiting factor related protein-8 (MRP8/S100A8) and allograft inflammatory factor-1 (AIF-1) following human traumatic brain injury. Acta Neuropathol 2000; 100: 627-34
42. Postler E, Lehr A, Schluesener H, Meyermann R. Expression of the S-100 proteins MRP-8 and -14 in ischemic brain lesions. Glia 1997; 19: 27-34
43. Schluesener HJ, Kremsner PG, Meyermann R. Widespread expression of MRP8 and MRP14 in human cerebral malaria by microglial cells. Acta Neuropathol 1998; 96: 575-80
44. Zeinstra E, Wilczak N, Streefland C, De Keyser J. Astrocytes in chronic active multiple sclerosis plaques express MHC class II molecules. Neuroreport 2000; 11: 89-91
45. Mori S, Leblond CP. Identification of microglia in light and electron microscopy. J Comp Neurol 1969; 135: 57-80
46. Lawson LJ, Perry VH, Dri P, Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 1990; 39: 151-70
47. Rezaie P, Patel K, Male DK. Microglia in the human fetal spinal cord - patterns of distribution, morphology and phenotype. Brain Res Dev Brain Res 1999; 115: 71-81
48. Rezaie P, Male D. Colonisation of the developing human brain and spinal cord by microglia: a review. Microsc Res Tech 1999; 45: 359-82
49. Koshinaga M, Whittemore SR. The temporal and spatial activation of microglia in fiber tracts undergoing anterograde and retrograde degeneration following spinal cord lesion. J Neurotrauma 1995; 12: 209-22
50. Morioka T, Kalehua AN, Streit WJ. The microglial reaction in the rat dorsal hippocampus following transient forebrain ischemia. J Cereb Blood Flow Metab 1991; 11: 966-73
51. Engelhardt JI, Appel SH. IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. Arch Neurol 1990; 47: 1210-16
52. Drew PD, Chavis JA. Inhibition of microglial cell activation by cortisol. Brain Res Bull 2000; 52: 391-6
53. Volk HD, Thieme M, Heym S, Docke WD, Ruppe U, Tausch W, Manger D, Zuckermann S, Golosubow A, Nieter B. Alterations in function and phenotype of monocytes from patients with septic disease - predictive value and new therapeutic strategies. Behring Inst Mitt 1991; 88: 208-15